Published 01:29 IST, October 22nd 2020

Putin affirms Russian population to be prioritised for COVID-19 vaccine over export

Amid the COVID-19 pandemic, Vladimir Putin reiterated his priorities about vaccinating Russians against COVID-19 over exporting the vaccine abroad on Wednesday

Reported by: Shubham Bose
Follow: Google News Icon
  • share
null | Image: self
Advertisement

Amid COVID-19 pandemic, Vlimir Putin reiterated his priorities about vaccinating Russians against COVID-19 over exporting vaccine abro on Wednesday, October 21. During a board meeting with Russian Union of Industrialists and Entrepreneurs, Putin is reported to have stated that while exporting potential COVID-19 vaccine was also important, it was still a ‘second question’ and that priority was to vaccinate Russians.

Re: Ukraine's Naftogaz Welcomes Expansion Of US Sanctions Against Russia's rd Stream 2

Advertisement

Russia first

Russian President during his dress said, " main task today is to create production capacities to increase output. And se production capacities should be aimed at vaccinating citizens of Russia in first place. As for export work, this is an important task, but, of course, you can just sell it, but better decide how: let our partners create such production facilities in ir countries, and we will organize for m production of our vaccine re, at ir production facilities".

Last week, Russian authorities gave regulatory approval to a second potential COVID-19 vaccine after encouraging early test results. This anuncement was me just two months after Russia anunced its first potential COVID-19 vaccine that drew criticisms from scientific community.

Advertisement

Re: Russia Calls For Collective Security In Gulf, US Blames Iran

second COVID-19 vaccine was anunced by Russian President Vlimir Putin on Wednesday, October 14 during a televised meeting. This vaccine has been developed by Vector Institute in Siberia and is called EpiVacCorona and is reported to have been alrey tested on 100 volunteers in early-st placebo-controlled human trials, which lasted more than two months. While official results from early trials are yet to be published, scientists involved with study have stated that vaccine protects person from COVID-19 for up to six months.

Advertisement

COVID-19 pandemic which saw its first outbreak in a wet market in Wuhan, China last year has w spre all across world. virus, named COVID-19 by World Health Organisation, has infected over 40 million people worldwide with global death toll crossing 1,100,000. Russia has reported more than 1 million positive COVID-19 cases and a death toll of over 20,000.

(With ANI inputs, Im AP)

Advertisement

Re: Elementary Pupils In Russia Return To Classrooms Amid Coronavirus Pandemic

Re: Russia Approves Second Virus Vaccine After Early Trials

Advertisement

01:29 IST, October 22nd 2020